Study of Sulfasalazine in Treating Painful Neuropathy
A Single-center, Randomized, Double-blind Clinical Study to Evaluate the Effect of Sulfasalazine on Painful Neuropathy
Sponsor: Massachusetts General Hospital
Terminated
poor enrollment
Other terminated trials from Massachusetts General Hospital
A PHASE2 clinical study on Painful Neuropathy, this trial is terminated or withdrawn. The trial is conducted by Massachusetts General Hospital and has accumulated 9 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Sep 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Sep 2018 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .